Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus

Clinical Rheumatology

Volumn 24, Issue 5, 2005, Pages 469-475

  Shimojima, Yasuhiro ^a   Matsuda, Masayuki ^a   Gono, Takahisa ^a   Ishii, Wataru ^a   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; Cerebrospinal fluid; Cytokine; Neuropsychiatric manifestation; Relapse; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; LA ANTIBODY; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COMPLEMENT BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ELECTROENCEPHALOGRAM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; JAPAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; MYELITIS; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PSYCHOSIS; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 30344466059     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1060-y     Document Type: Article

References (34)

1. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496-500
2. Hanly JG (2001) Neuropsychiatric lupus. Curr Rheumatol Rep 3:205-212
3. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599-608
4. Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B (1992) Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 19:562-567
5. Jennekens FG, Kater L (2002) The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: A literature investigation. Rheumatology (Oxford) 41:619-630
6. Hirohata S, Miyamoto T (1990) Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 33:644-649
7. Hirohata S, Kosaka M (1994) Association of anti-Sm antibodies with organic brain syndrome secondary to systemic lupus erythematosus. Lancet 343:796
8. Swaak AJ, Huysen V, Nossent JC, Smeenk RJ (1990) Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus. Clin Rheumatol 9:82-94
9. Silva LM, Garcia AB, Donadi EA (2002) Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations. J Neurol 249:1048-1054
10. Isshi K, Hirohata S (1998) Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 41:1819-1827
11. Gerli R, Caponi L, Tincani A, Scorza R, Sabbadini MG, Danieli MG et al (2002) Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: Prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) 41:1357-1366
12. Yoshio T, Masuyama J, Kano S (1996) Antiribosomal P0 protein antibodies react with the surface of human umbilical vein endothelial cells. J Rheumatol 23:1311-1312
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277 1:STN:280:BiyD2cfksFI%3D
14. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725 1:STN:280:ByiH28vitFU%3D
15. Finn R, de M Rudolf N (1978) The electroencephalogram in systemic lupus erythematosus. Lancet 1:1255
16. Ishikawa O, Ohnishi K, Miyachi Y, Ishizaka H (1994) Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody. J Rheumatol 21:87-90
17. Sibbitt WL Jr, Schmidt PJ, Hart BL, Brooks WM (2003) Fluid attenuated inversion recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus. J Rheumatol 30:1983-1989
18. Small P, Mass MF, Kohler PF, Harbeck RJ (1977) Central nervous system involvement in SLE. Diagnostic profile and clinical features. Arthritis Rheum 20:869-878
19. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630-640 1:STN:280:By2B1cjhvVA%3D
20. Hirohata S, Hirose S, Miyamoto T (1985) Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Arch Intern Med 145:1843-1846
21. Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG (1995) Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 98:32-41 10.1016/ S0002-9343(99)80078-3
22. Hanly JG, Walsh NM, Sangalang V (1992) Brain pathology in systemic lupus erythematosus. J Rheumatol 19:732-741
23. Devinsky O, Petito CK, Alonso DR (1988) Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 23:380-384
24. Zvaifler NJ, Bluestein HG (1982) The pathogenesis of central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 25:862-866
25. Ellis SG, Verity MA (1971) Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 8:212-221
26. Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F et al (2003) Neuropsychiatric lupus syndromes: Relationship with antiphospholipid antibodies. Neurology 61:108-110
27. Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA et al (2000) Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 109:628-634
28. Sabet A, Sibbitt WL Jr, Stidley CA, Danska J, Brooks WM (1998) Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 29:2254-2260
29. Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA III, Koffler D (1983) Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 74:837-844
30. McLean BN, Miller D, Thompson EJ (1995) Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. J Neurol Neurosurg Psychiatry 58:548-554
31. Pradhan VD, Badakere SS, Bichile LS, Dolas MP (2002) Antibodies to Ro/ SS-A and La/SS-B in systemic lupus erythematosus and other autoimmune disorders. J Assoc Physicians India 50:762-765
32. Hirohata S, Hayakawa K (1999) Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 42:2729-2730
33. Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T (1992) Interferon-alpha in lupus psychosis. Arthritis Rheum 35:417-422
34. El-Zorkany BK, Mahmoud GA, Shahin HA, Moustafa H, Shahin AA (2003) Tumor necrosis factor-alpha and neuropsychiatric lupus erythematosus: Relation to single photon emission computed tomography findings. Mod Rheumatol 13:250-255